TEYI PHARMACEUTICAL GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.38 CNY | -1.78% |
|
-18.33% | -26.72% |
| Apr. 19 | Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 29 | Teyi Pharmaceutical Group Co.,Ltd Approves the Cash Dividend for 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9.38
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.72% | 661M | |
| +25.83% | 661B | |
| +26.56% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.75% | 231B | |
| +5.29% | 200B | |
| -8.83% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002728 Stock
- News Teyi Pharmaceutical Group Co.,Ltd
- Teyi Pharmaceutical's Hypertension Drug Passes Regulatory Evaluation
